Preventive treatments to slow substantia nigra damage and Parkinson’s disease progression: A critical perspective review-Reference-Cited by-同舟云学术

Preventive treatments to slow substantia nigra damage and Parkinson’s disease progression: A critical perspective review

Published:2020-11 Issue: Volume:161 Page:105065
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Bjørklund Geir,Dadar Maryam,Anderson George,Chirumbolo Salvatore,Maes Michael

Publisher

Elsevier BV

Subject

Pharmacology

Reference164 articles.

1. Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson’s disease: evidence for dopaminergic basis?;Qamar;NPJ Parkinson’s Dis.,2017

2. Staging of serotonergic dysfunction in Parkinson’s disease: an in vivo 11C-DASB PET study;Politis;Neurobiol. Dis.,2010

3. Non-motor Parkinson’s: integral to motor Parkinson’s, yet often neglected;Todorova;Pract. Neurol.,2014

4. Non-motor symptoms of Parkinson’s disease: dopaminergic pathophysiology and treatment;Chaudhuri;Lancet Neurol.,2009

5. Alpha-Synuclein posttranslational modification and alternative splicing as a trigger for neurodegeneration;Beyer;Mol. Neurobiol.,2013

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between dietary niacin intake and risk of Parkinson’s disease in US adults: cross-sectional analysis of survey data from NHANES 2005–2018;Frontiers in Nutrition;2024-07-18

2. From the Gut to the Brain: Is Microbiota a New Paradigm in Parkinson’s Disease Treatment?;Cells;2024-04-30

3. Melatonin as a Mediator of the Gut Microbiota–Host Interaction: Implications for Health and Disease;Antioxidants;2023-12-23

4. Reversing memory/cognitive impairment with medicinal plants targeting inflammation and its crosstalk with other pathologies;Brain Disorders;2023-09

5. Pathways to healing: Plants with therapeutic potential for neurodegenerative diseases;IBRO Neuroscience Reports;2023-06